craft-sa-dev Home  

PMC:1448208 / 31878-32301 JSONTXT 4 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T16944 0-2 IN denotes In
T16946 3-10 NN denotes summary
T16947 10-12 , denotes ,
T16948 12-17 DT denotes these
T16950 18-27 VBG denotes surviving
T16949 28-32 NNS denotes mice
T16945 33-36 VBD denotes had
T16951 37-41 NN denotes BCAA
T16953 41-42 HYPH denotes /
T16952 42-49 NN denotes alanine
T16954 50-56 NNS denotes ratios
T16955 57-61 WDT denotes that
T16956 62-66 VBD denotes were
T16957 67-79 JJ denotes intermediate
T16958 80-87 IN denotes between
T16959 88-96 NNS denotes controls
T16960 97-100 CC denotes and
T16961 101-110 NNS denotes knockouts
T16962 111-114 CC denotes and
T16963 115-119 PRP denotes they
T16964 120-129 VBD denotes expressed
T16965 130-131 SYM denotes ~
T16967 131-132 CD denotes 5
T16968 132-133 SYM denotes –
T16966 133-134 CD denotes 6
T16969 134-135 NN denotes %
T16970 136-138 IN denotes of
T16971 139-145 JJ denotes normal
T16973 146-151 NN denotes BCKDH
T16974 152-158 NN denotes enzyme
T16972 159-167 NN denotes activity
T16975 168-170 IN denotes in
T16976 171-174 DT denotes the
T16977 175-180 NN denotes liver
T16978 180-181 . denotes .
T16979 181-333 sentence denotes These phenotypic observations are remarkably similar to the clinical phenotype observed in MSUD patients with the intermediate form of the disease [1].
T16980 182-187 DT denotes These
T16982 188-198 JJ denotes phenotypic
T16981 199-211 NNS denotes observations
T16983 212-215 VBP denotes are
T16984 216-226 RB denotes remarkably
T16985 227-234 JJ denotes similar
T16986 235-237 IN denotes to
T16987 238-241 DT denotes the
T16989 242-250 JJ denotes clinical
T16988 251-260 NN denotes phenotype
T16990 261-269 VBN denotes observed
T16991 270-272 IN denotes in
T16992 273-277 NN denotes MSUD
T16993 278-286 NNS denotes patients
T16994 287-291 IN denotes with
T16995 292-295 DT denotes the
T16997 296-308 JJ denotes intermediate
T16996 309-313 NN denotes form
T16998 314-316 IN denotes of
T16999 317-320 DT denotes the
T17000 321-328 NN denotes disease
T17001 329-330 -LRB- denotes [
T17002 330-331 CD denotes 1
T17003 331-332 -RRB- denotes ]
T17004 332-333 . denotes .
T17005 333-423 sentence denotes Thus, these rescue mice represent a very useful model of the intermediate MSUD phenotype.
T17006 334-338 RB denotes Thus
T17008 338-340 , denotes ,
T17009 340-345 DT denotes these
T17011 346-352 NN denotes rescue
T17010 353-357 NNS denotes mice
T17007 358-367 VBP denotes represent
T17012 368-369 DT denotes a
T17014 370-374 RB denotes very
T17015 375-381 JJ denotes useful
T17013 382-387 NN denotes model
T17016 388-390 IN denotes of
T17017 391-394 DT denotes the
T17019 395-407 JJ denotes intermediate
T17020 408-412 NN denotes MSUD
T17018 413-422 NN denotes phenotype
T17021 422-423 . denotes .
R4849 T16944 T16945 prep In,had
R4850 T16946 T16944 pobj summary,In
R4852 T16947 T16945 punct ", ",had
R4853 T16948 T16949 det these,mice
R4855 T16949 T16945 nsubj mice,had
R4856 T16950 T16949 amod surviving,mice
R4857 T16951 T16952 compound BCAA,alanine
R4858 T16952 T16954 compound alanine,ratios
R4860 T16953 T16952 punct /,alanine
R4861 T16954 T16945 dobj ratios,had
R4862 T16955 T16956 dep that,were
R4864 T16956 T16954 relcl were,ratios
R4865 T16957 T16956 acomp intermediate,were
R4866 T16958 T16957 prep between,intermediate
R4868 T16959 T16958 pobj controls,between
R4869 T16960 T16959 cc and,controls
R4870 T16961 T16959 conj knockouts,controls
R4871 T16962 T16945 cc and,had
R4872 T16963 T16964 nsubj they,expressed
R4874 T16964 T16945 conj expressed,had
R4875 T16965 T16966 punct ~,6
R4878 T16966 T16969 nummod 6,%
R4880 T16967 T16966 quantmod 5,6
R4881 T16968 T16966 punct –,6
R4882 T16969 T16964 dobj %,expressed
R4884 T16970 T16969 prep of,%
R4885 T16971 T16972 amod normal,activity
R4887 T16972 T16970 pobj activity,of
R4888 T16973 T16972 compound BCKDH,activity
R4889 T16974 T16972 compound enzyme,activity
R4891 T16975 T16972 prep in,activity
R4892 T16976 T16977 det the,liver
R4894 T16977 T16975 pobj liver,in
R4895 T16978 T16945 punct .,had
R4897 T16980 T16981 det These,observations
R4899 T16981 T16983 nsubj observations,are
R4900 T16982 T16981 amod phenotypic,observations
R4901 T16984 T16985 advmod remarkably,similar
R4902 T16985 T16983 acomp similar,are
R4904 T16986 T16985 prep to,similar
R4905 T16987 T16988 det the,phenotype
R4906 T16988 T16986 pobj phenotype,to
R4909 T16989 T16988 amod clinical,phenotype
R4911 T16990 T16988 acl observed,phenotype
R4912 T16991 T16990 prep in,observed
R4913 T16992 T16993 compound MSUD,patients
R4915 T16993 T16991 pobj patients,in
R4916 T16994 T16993 prep with,patients
R4917 T16995 T16996 det the,form
R4919 T16996 T16994 pobj form,with
R4920 T16997 T16996 amod intermediate,form
R4921 T16998 T16996 prep of,form
R4922 T16999 T17000 det the,disease
R4923 T17000 T16998 pobj disease,of
R4924 T17001 T17002 punct [,1
R4926 T17002 T16983 parataxis 1,are
R4927 T17003 T17002 punct ],1
R4928 T17004 T16983 punct .,are
R4930 T17006 T17007 advmod Thus,represent
R4932 T17008 T17007 punct ", ",represent
R4933 T17009 T17010 det these,mice
R4934 T17010 T17007 nsubj mice,represent
R4936 T17011 T17010 compound rescue,mice
R4937 T17012 T17013 det a,model
R4938 T17013 T17007 dobj model,represent
R4940 T17014 T17015 advmod very,useful
R4941 T17015 T17013 amod useful,model
R4943 T17016 T17013 prep of,model
R4944 T17017 T17018 det the,phenotype
R4945 T17018 T17016 pobj phenotype,of
R4947 T17019 T17018 amod intermediate,phenotype
R4948 T17020 T17018 compound MSUD,phenotype
R4949 T17021 T17007 punct .,represent